IFCI research, Equity Buy/Sell (Technical View) 14 Feb 11

Please Share:: India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

Equity Buy/Sell (Technical View)

Ø  The following scrips look good - we would however advise short term and medium term investors to book profits on a 8-10% return.

o   ACC > 1000 ; Auro Pharma > 243 ; Bank India > 420 ; Glaxo > 2120 ;

o   Gitanjali Gems > 229 ; KPIT > 145 ; PNB > 1078 ; TCS > 1130.

Ø  We have been advising support levels for many scrips. Many of them have bounced up from exactly the levels –

o   ACC from 922/20 ( 930 support) ; Axis Bk. from 1149 ( support 1150) ;

o   Bank Baroda from 798 ( support 800)  ; BHEL from 2000  (support 2000) ;

o   Tata Steel from 575 ( support 575) to name a few.

Have Strict Stop Loss